Injections of the Hip and Knee

Charles W. Webb, DO
Geoff McLeod, DO
Rathna Nuti, MD

American Family Physician. 2024;109(1):61-70.

Author disclosure: No relevant financial relationships.

This is one of a series of articles produced in collaboration with the American Medical Society for Sports Medicine.

Hip and knee injections are useful diagnostic and therapeutic tools for family physicians. This article reviews anatomic landmark–guided and ultrasound-guided injections and aspiration techniques for greater trochanteric pain syndrome, the hip joint, the knee joint, the pes anserine bursa, and the iliotibial band. Indications for injections include acute and chronic inflammatory conditions, such as rheumatoid arthritis; osteoarthritis; overuse; and traumas. Joint aspirations may be performed to aid in the diagnosis of unexplained effusions and to relieve pain. Technique, injectant, and follow-up timing depend on the physician's comfort, experience, and preference. Infections of the skin or soft tissue are the primary contraindications to injections. The most common complications are local inflammatory reactions to the injectant. These reactions usually cause soreness for 24 to 48 hours, then spontaneously resolve. Follow-up after injections is usually scheduled within two to six weeks.

Family physicians often use joint injections for the diagnosis and treatment of common musculoskeletal conditions. This review discusses techniques using anatomic landmark–guided and ultrasound-guided injections and aspiration for the hip and knee; however, many other techniques are also available for injections. Family physicians are becoming more comfortable with the use of point-of-care ultrasonography (POCUS) for diagnosis and guided procedures; however, the terminology and techniques of POCUS are beyond the scope of this article. Intra-articular injections guided by POCUS are more accurate than anatomic landmark–guided injections of the hip and knee.110

SORT: KEY RECOMMENDATIONS FOR PRACTICE

A = consistent, good-quality patient-oriented evidence; B = inconsistent or limited-quality patient-oriented evidence; C = consensus, disease-oriented evidence, usual practice, expert opinion, or case series. For information about the SORT evidence rating system, go to https://www.aafp.org/afpsort.

Table 1 provides commonly reported needle, steroid, and anesthetic combinations.11,12 Table 2 identifies common steroids and the duration of action.12 Table 3 reviews the approximate duration of onset and action for anesthetics.12 eTable A compares the accuracy rates of hip and knee injection techniques using landmark and ultrasound guidance. eTable B provides resources for learning about POCUS.

TABLE 1. Common Needle, Steroid, and Anesthetic Combinations for Knee and Hip Injections

SiteType of needleSteroid optionsAnesthetic
Greater trochanter22 gauge, 1.5 or 3.5 inch (depending on the body habitus of the patient)Betamethasone, 6 mg
Dexamethasone, 8 mg
Methylprednisolone, 40 mg
Triamcinolone, 40 mg
5 mL of lidocaine 1% or bupivacaine 0.25% or 0.5%
Hip joint22 gauge, 3.5 inchBetamethasone, 6 mg
Dexamethasone, 8 mg
Methylprednisolone, 40 mg
Triamcinolone, 40 mg
3 mL of bupivacaine 0.25% or 0.5%
Knee joint21 or 22 gauge, 1.5 inchBetamethasone, 6 mg
Dexamethasone, 8 mg
Methylprednisolone, 40 mg
Triamcinolone, 40 mg
5 to 7 mL of lidocaine 1% or bupivacaine 0.25% or 0.5%
Pes anserine bursa22 gauge, 1.5 inchBetamethasone, 3 to 6 mg
Dexamethasone, 4 to 8 mg
Methylprednisolone, 20 to 40 mg
Triamcinolone, 10 to 40 mg
2 mL of lidocaine 1% or bupivacaine 0.25% or 0.5%
Iliotibial band22 gauge, 1.5 inchBetamethasone, 3 to 6 mg
Dexamethasone, 4 to 8 mg
Methylprednisolone, 20 to 40 mg
Triamcinolone, 10 to 40 mg
2 mL of lidocaine 1% or bupivacaine 0.25% or 0.5%

Adapted with permission from Cardone DA, Tallia AF. Diagnostic and therapeutic injection of the hip and knee. Am Fam Physician. 2003;67(10):2148, with additional information from reference 12.

TABLE 2. Duration of Action of Steroids Commonly Used in Hip and Knee Injections

SteroidApproximate duration of action in days
Dexamethasone sodium6
Dexamethasone acetate8
Methylprednisolone acetate8
Betamethasone acetate14
Triamcinolone acetate14
Triamcinolone hexacetonide21

Adapted with permission from Stephens MB, Beutler AI, O'Connor FG. Musculoskeletal injections: a review of the evidence. Am Fam Physician. 2008;78(8):975.

TABLE 3. Summary of Anesthetics Commonly Used in Hip and Knee Injections

AnestheticOnset of action (minutes)Duration of action (hours)Maximum volume of injection (mL)*
Bupivacaine 0.25%30860
Bupivacaine 0.5%30830
Lidocaine 1%1 to 2120
Lidocaine 2%1 to 2110

*—There is an increased risk of cardiac toxicity or arrhythmia above these volumes.

Adapted with permission from Stephens MB, Beutler AI, O'Connor FG. Musculoskeletal injections: a review of the evidence. Am Fam Physician. 2008;78(8):975.

eTABLE A Accuracy Comparison Between Anatomic Landmark–Guided and Ultrasound-Guided Hip and Knee Injections

AuthorType of studySample sizeAccuracy of landmark-guided injections (%)Accuracy of ultrasound-guided injections (%)
Hip joint
Diraçoğlu, et al.Cohort16 patients66.7
LeviRetrospective review11 patients100
Pourbagher, et al.Case series10 patients100
Smith, et al.Cohort28 patients97
Ziv, et al.Cohort40 patients77.5
Knee joint
Berkoff, et al.Meta-analysis5 studies77.895.8
Curtiss, et al.Cohort20 patients55 (less experienced clinician)
100 (experienced clinician; superolateral)
100 (any clinician; superolateral)
Daley, et al.Systematic review11 studies70 (medial)
83 (superolateral)
84 (lateral midpatellar)
99 (superolateral)
Esenyel, et al.Cohort39 patients56 (medial midpatellar)
73 (anteromedial)
76 (lateral midpatellar)
85 (anterolateral)
Hermans, et al.Systematic review9 studies67 (anterolateral)
72 (anteromedial)
85 (lateral midpatellar)
91 (superolateral)
Jackson, et al.Cohort240 patients71 (anterolateral)
75 (anteromedial)
93 (lateral midpatellar)
Lopes, et al.Case series37 patients100 (superolateral)

Information from:

Berkoff DJ, Miller LE, Block JE. Clinical utility of ultrasound guidance for intra-articular knee injections: a review. Clin Interv Aging. 2012;7:89–95.

Curtiss HM, Finnoff JT, Peck E, et al. Accuracy of ultrasound-guided and palpation-guided knee injections by an experienced and less-experienced injector using a superolateral approach: a cadaveric study. PM R. 2011;3(6):507–515.

Daley EL, Bajaj S, Bisson LJ, et al. Improving injection accuracy of the elbow, knee, and shoulder: does injection site and imaging make a difference? A systematic review. Am J Sports Med. 2011;39(3):656–662.

Daniels EW, Cole D, Jacobs B, et al. Existing evidence on ultrasound-guided injections in sports medicine. Orthop J Sports Med. 2018;6(2):2325967118756576.

Diraçoğlu D, Alptekin K, Dikici F, et al. Evaluation of needle positioning during blind intra-articular hip injections for osteoarthritis: fluoroscopy versus arthrography. Arch Phys Med Rehabil. 2009;90(12):2112–2115.

Esenyel C, Demirhan M, Esenyel M, et al. Comparison of four different intra-articular injection sites in the knee: a cadaver study. Knee Surg Sports Traumatol Arthrosc. 2007;15(5):573–577.

Hermans J, Bierma-Zeinstra SMA, Bos PK, et al. The most accurate approach for intra-articular needle placement in the knee joint: a systematic review. Semin Arthritis Rheum. 2011;41(2):106–115.

Jackson DW, Evans NA, Thomas BM. Accuracy of needle placement into the intra-articular space of the knee. J Bone Joint Surg Am. 2002;84(9):1522–1527.

Levi DS. Intra-articular hip injections using ultrasound guidance: accuracy using a linear array transducer. PM R. 2013;5(2):129–134.

Pourbagher MA, Ozalay M, Pourbagher A. Accuracy and outcome of sonographically guided intra-articular sodium hyaluronate injections in patients with osteoarthritis of the hip. J Ultrasound Med. 2005;24(10):1391–1395.

Smith J, Hurdle MFB, Weingarten TN. Accuracy of sonographically guided intra-articular injections in the native adult hip. J Ultrasound Med. 2009;28(3):329–335.

Ziv YB, Kardosh R, Debi R, et al. An inexpensive and accurate method for hip injections without the use of imaging. J Clin Rheumatol. 2009;15(3):103–105.

eTABLE B Resources for Learning About Point-of-Care Ultrasonography

ResourceCostComments
American College of Emergency Physicians Sonoguide
https://www.acep.org/sonoguide
FreeOnline curriculum of test-based descriptions with photos and videos; referenced by Ultrasound Ninja curriculum; developed for emergency department clinicians
American Institute of Ultrasound in Medicine
https://www.aium.org
Prices vary by course and CME creditsCollection of CME materials for ultrasound certification; credentialing program recommending 50 credits in each body area; links to recent articles on point-of-care ultrasonography
American Medical Society for Sports Medicine
https://www.amssm.org/Onlinelearning-CME.php
https://www.amssm.org/US-Case-Studies.php
FreeCollection of short videos demonstrating examination of the musculoskeletal system and ultrasound-guided injections; library of case studies with teaching pearls
Core Ultrasound
https://coreultrasound.com/5ms
FreeCollection of short videos demonstrating examinations; podcast; course for beginners, including an introduction to basic ultrasonography (fee required for courses)
Point-of-Care Ultrasound Certification Academy
https://pocus.org
$125 for fundamental certification; $150 for each of 10 clinical area certificates; $625 for emergency medicine certification with seven clinical areasCertification programs, including examination and certificate; collection of webinars, podcasts, and other clinical programs
SonoSpot: Topics in Bedside Ultrasound
http://sonospot.com
FreeTutorials with photos and verbal descriptions for probe placement; short videos of ultrasound images showing expected results
Ultrasound Ninja
http://www.ultrasoundninja.com
FreeEmergency medicine ultrasound program; curriculum consisting of podcasts and references for each curricular element; free e-book

Adapted with permission from Arnold MJ, Jonas CE, Carter RE. Point-of-care ultrasonography. Am Fam Physician. 2020;101(5):283.

Greater Trochanteric Pain Syndrome

Patients with tenderness to palpation over the greater trochanter may have greater trochanteric bursitis, gluteal tendinitis, or both. Greater trochanter pain syndrome presents with pain over the lateral hip around the greater trochanter that is worse with lying down on the affected side, passive stretching, and eccentric loading of the external rotators.13,14

ANATOMY

The greater trochanter of the femur comprises four facets. The gluteus minimus tendon attaches to the anterior facet. The gluteus medius tendon is comprised of anterior and posterior bands that attach to the lateral and superior posterior facets. The iliotibial band overlies the gluteus minimus and medius muscles. There are three bursas located in the greater trochanteric region of the hip. The greater trochanteric bursa is between the iliotibial band and the gluteus medius and minimus tendons. The subgluteus minimus bursa is between the gluteus minimus tendon and the femur. The subgluteus medius bursa is between the gluteus medius tendon and the femur.1418

ANATOMIC TECHNIQUE

The patient is in the lateral recumbent position with the painful hip up. The hip and knee are flexed 30 to 50 degrees and 60 to 90 degrees, respectively. The greater trochanter is palpated, and the injection site is the point of maximal tenderness (eFigure A). After the skin is cleaned, a 22- or 25-gauge, 1.5-inch or 3.5-inch needle (depending on the patient's body habitus) is inserted perpendicular to the skin directly toward the greater trochanter and then withdrawn 2 to 3 mm. The injectant should flow easily.

eFIGURE A

Greater trochanter pain syndrome point of maximal tenderness injection site.

ULTRASOUND TECHNIQUE

The patient is in the lateral recumbent position with the painful hip up. The 5 MHz curvilinear transducer is placed horizontally on the greater trochanter transverse to the femur. The anterior, lateral, and posterior facets are identified. Directly above the lateral facet is the anterior band of the gluteus medius tendon, and the iliotibial band is above that. The needle is inserted in a long axis with the probe from posterior to anterior, targeting the space between the gluteus medius tendon and the iliotibial band14,16,17,19 (Figure 1; https://youtu.be/zkqjTQhn-vs).

FIGURE 1.

Ultrasound image of the greater trochanter. Gluteus maximus tendon (red). Gluteus medius tendon (blue). Greater trochanter (yellow). Greater trochanter bursa (dashed arrow). Subgluteal medius bursa (solid arrow). Direction and course of the needle for the injection (green arrow).

Hip Joint Pain

Indications for aspiration or injection of the hip joint include osteoarthritis, inflammatory arthritis, infectious conditions, femoroacetabular impingement, and osteonecrosis. These conditions can cause pain in the groin or thigh that radiates to the buttocks, lower back, or knee with varying degrees of stiffness and locking.1,2,16,17,19,20 Intra-articular injections (with or without corticosteroids) may be used as an adjunct for short and intermediate pain relief and improved function in patients with osteoarthritis of the hip.12,14,15,2124

ANATOMY

The femoroacetabular joint is a ball-and-socket synovial joint consisting of a bony acetabulum and femoral head with a fibrocartilaginous labrum that stabilizes the joint. The joint capsule originates superior to the labrum and extends distally to the intertrochanteric line of the femur.1,2,16,19,20

ANATOMIC TECHNIQUE

The patient is in the supine position, with the physician standing next to the painful hip. The injection site is the intersection of a sagittal line drawn distally from the anterosuperior iliac spine and a line drawn transversely from the proximal tip of the greater trochanter (Figure 2). The injection site should be approximately 3 cm lateral from the femoral artery. After the skin has been cleaned, a 22-gauge, 3.5-inch needle is directed posteriorly toward the femoral neck until the needle tip contacts the junction of the femoral head and neck. The needle is withdrawn 1 to 2 mm, and the plunger is retracted to ensure no blood is present before the injection is performed.

FIGURE 2.

Diagram for anatomic landmark–guided injection. Injection site is a sagittal line drawn distally from the anterior superior iliac spine and a line drawn transversely from the proximal tip of the greater trochanter. The needle should be directed posteriorly toward the femoral neck (green arrow), to avoid the femoral artery. Landmark-guided hip injection has fallen out of favor with the increased availability of point-of-care ultrasonography.

ULTRASOUND TECHNIQUE

The patient is in the supine position, with the 5 MHz curvilinear transducer placed along the femoral neck in a longitudinal, oblique plane. The anterior recess is seen in this position, and any effusion can be identified. After finding the femoral head, the transducer can be moved distally to locate the junction of the femoral neck and head in the axial plane. After the skin has been cleaned, a 22-gauge, 3.5-inch needle is inserted from the lateral side in the long axis of the probe (Figure 3). When the needle is seen in the joint capsule next to the bone, the injection can be performed1,2,16,19,20 (https://youtu.be/zkqjTQhn-vs).

FIGURE 3.

Ultrasound image of the femoral acetabular joint. Acetabulum (blue). Femoral head (yellow). Joint capsule (red). Needle trajectory into the joint capsule (green arrow).

Knee Joint Pain

Pain relief is the primary indication for knee joint injection or aspiration. Aspiration of the knee joint decreases intra-articular pressure, relieving pain. Any fluid obtained can be analyzed to confirm a diagnosis.25,26 Most physicians perform landmark-guided injections for the knee despite multiple studies demonstrating increased accuracy and improved outcomes with ultrasound guidance. Physicians may be more likely to use ultrasound guidance when landmarks are difficult to locate, such as with a history of trauma to the knee or morbid obesity. A systematic review found that knee joint injections are most accurate using the superior lateral approach, with or without ultrasonography.27,28 Intra-articular injections (with or without corticosteroids) may be used as an adjunct for short and intermediate pain relief and improved function in patients with osteoarthritis of the knee.11,12,15,2125,2932

ANATOMY

The knee is the largest synovial joint. It comprises a hinge joint with the femoral condyles superiorly, the tibial plateau inferiorly, the patella (sesamoid bone) anteriorly, and two fibrocartilaginous menisci between the tibia and the femur, which act as guides for the femur to glide on top of the tibia33,34 (Figure 435 ).

FIGURE 4.

Anterior view of the knee demonstrating the cartilaginous components, including the menisci.

Reprinted with permission from Tandeter HB, Shvartzman P, Stevens MA. Acute knee injuries: use of decision rules for selective radiograph ordering. Am Fam Physician. 1999;60(9):2600.

SUPINE ANATOMIC TECHNIQUE

The patient is in the supine position with the knee slightly flexed (15 to 20 degrees) and supported by a foam roll, pillow, or rolled towel. Lines are drawn along the lateral and superior margins of the patella (Figure 5). A 22-gauge, 1.5-inch needle is inserted into the soft tissue between the patella and the femur at the intersection of these two lines. The needle should be aimed toward the middle of the medial side of the joint (approximately a 45-degree angle). The injectant flow should be even with no resistance.27,28,36,37

FIGURE 5.

Supine anatomic knee injection. The intersection of lines along the lateral and superior margins of the patella demarcates the location for the injection (green arrow).

SEATED ANATOMIC TECHNIQUE

The patient is seated at the end of the examination table. The physician palpates up from the tibia tubercle along the patellar tendon, then moves laterally or medially to the soft tissue between the femur and tibia. A 22-gauge, 1.5-inch needle is inserted parallel to the floor, aiming toward the center of the joint (Figure 6).

FIGURE 6.

Seated anatomic knee injection. Palpate up from the tibia tubercle along the patellar tendon, then move laterally or medially to the soft tissue between the femur and tibia to find the injection site (green arrow).

ULTRASOUND TECHNIQUE

The patient is in the supine position with the knee slightly flexed. The 12 MHz linear array probe is placed superolaterally to the patella with the beam directed medially toward the patellofemoral space (Figure 7). The image seen from anterior to posterior includes the quadriceps tendon, suprapatellar fat pad, suprapatellar pouch, and femur (Figure 8). A 22-gauge, 1.5-inch needle is inserted in the long axis with the probe directed into the suprapatellar pouch34,36 (Figure 9; https://youtu.be/qKQKzFQgYAs).

FIGURE 7.

Position of the ultrasound probe on the patient for ultrasound-guided knee injection.

FIGURE 8.

Ultrasound image of the knee. Quadriceps tendon (red). Patella (blue). Suprapatellar fat pad (yellow). Suprapatellar pouch (black). Femur (green).

FIGURE 9.

Ultrasound image of the knee, without the patella. This is the preferred image when using this technique. Quadriceps tendon (red). Needle trajectory into the suprapatellar pouch (green arrow).

Pes Anserine Bursitis

Patients with pes anserine bursitis report pain and swelling on the medial side of the knee, directly over the pes anserine insertion. The pain may radiate proximally when palpated along the semitendinosus tendon. The pain gradually increases with running and especially with climbing stairs.34

ANATOMY

The pes anserine bursa is located 2 cm distal to the tibial plateau on the medial side of the knee and is the insertion of the pes anserine tendon, which is the combination of the sartorius, gracilis, and semitendinosus muscles.

ANATOMIC TECHNIQUE

The patient is supine with the knee slightly flexed (10 to 20 degrees) or seated with the knee flexed 90 degrees. The pes anserine tendon and its associated muscles can be located by having the patient flex the knee against resistance. The tendons can be palpated and followed distally to their insertion on the tibia. The bursa is the area of tenderness just proximal to the insertion point. The needle is inserted into the bone at the area of maximal tenderness and then withdrawn 2 to 3 mm (Figure 10).

FIGURE 10.

Knee position for pes anserine bursa anatomic injection.

ULTRASOUND TECHNIQUE

The patient is supine with the hip externally rotated and the knee slightly flexed. The 12 MHz linear array probe is placed in the coronal plane over the anterior fibers of the distal medial collateral ligament. Deep to the pes anserine fibers and superficial to the medial collateral ligament, the pes anserine bursa can be identified as the target when it contains fluid. A 22-gauge, 1.5-inch needle is directed into the bursa in the long axis with the probe 11,34 (Figure 11; https://youtu.be/C4NmmyzvbcA).

FIGURE 11.

Ultrasound image of pes anserine bursa (white arrow). Pes anserine tendon (red). Medial collateral ligament (blue). Tibia (yellow). Needle trajectory and the target line of the bursa (green arrow).

Iliotibial Band Syndrome

Patients with iliotibial band syndrome present with pain at the lateral femoral condyle or its insertion at the proximal tibia. The pain worsens with activity, running, or walking and improves with rest.

ANATOMY

The iliotibial band begins at the iliac crest and runs down the leg to the tibia, attaching to the Gerdy tubercle (Figure 1238 ). The iliotibial band helps abduct and stabilize the hip during a single-leg stance. Overuse can cause pain, tightness of the tensor fasciae latae muscle, pes cavus, and/or gluteal muscle weakness.

FIGURE 12. Iliotibial band anatomy.

Iliotibial band anatomy.

Reprinted with permission from Khaund R, Flynn SH. Iliotibial band syndrome: a common source of knee pain. Am Fam Physician. 2005;71(8):1546.

Patients with pain at the distal femoral condyle (Noble compression test) or over the Gerdy tubercle should have a positive Ober sign with tightness of the iliotibial band at the greater trochanter. The Ober test is performed by having the patient lie on the unaffected side with the physician stabilizing the affected pelvis. The physician passively flexes, abducts, and extends the affected hip with the knee flexed 90 degrees until it is aligned with the patient's trunk, then lowers the knee to the table. If the affected knee reaches the table (the level of the unaffected leg) with no pain, the test result is normal. If pain is felt or the knee is not able to reach the unaffected leg, the test result is positive, indicating a tight iliotibial band.38

ANATOMIC TECHNIQUE

The patient is in the lateral recumbent or supine position. The knee is flexed 20 to 30 degrees or over a pillow or rolled towel. The iliotibial band is palpated over the femoral condyle to insertion at the Gerdy tubercle. A 22-gauge, 1.5-inch needle is then inserted into the point of maximal tenderness near the lateral femoral condyle11 (Figure 13).

FIGURE 13.

Knee position for anatomic iliotibial band injection (green arrow).

ULTRASOUND TECHNIQUE

The patient is in the lateral recumbent position with the knee flexed to 20 to 30 degrees. The 12 MHz linear array probe is placed on the long axis over the iliotibial band, with the iliotibial band and the lateral femoral condyle in view. A collection of fluid between the iliotibial band and the lateral femoral condyle is the target for the injection (Figure 14). A 22-gauge, 1.5-inch needle is used for the injection, using an out-of-plane ultrasound technique with the needle perpendicular to the probe (https://youtu.be/qKQKzFQgYAs).

FIGURE 14.

Ultrasound image of the iliotibial band over the lateral femoral condyle. Iliotibial band (blue). Lateral femoral condyle (yellow). Needle trajectory into the target of the potential fluid collection (green arrow).

Contraindications

There are few contraindications for injections that are not related to the actual injectant. Superficial skin or soft tissue infections are contraindications because injections could potentially seed the joint or bursa. Aspiration can be therapeutic (pain relieving) and diagnostic if a joint infection is suspected. Unstable coagulopathies and fractures are relative contraindications; however, patients with hemarthrosis may benefit from pain-relieving aspirations.2,21,29,30

Aftercare

Following the aspiration of a bursa, especially those that are more superficially located, a pressure dressing should be used to limit the accumulation of fluid. Following any injection or aspiration of a joint or bursa, patients should be advised to avoid strenuous activity for several days. Patients should also be advised that a steroid flare-up may occur in the first 24 to 48 hours after injection. Pain, soreness, or irritation that worsens or lasts more than 72 to 96 hours after injection can be a sign of iatrogenic infection, and the patient should be reevaluated as soon as possible. All patients should have a follow-up appointment scheduled for two to six weeks postinjection.11,26,29,38

This article updates a previous article on this topic by Cardone and Tallia.11

Data Sources: A PubMed search was completed in Clinical Queries using the key terms injection technique, ultrasound, landmark, hip, and knee. The search included meta-analyses, randomized controlled trials, and systematic reviews. Also searched were the Cochrane database, DynaMed, and UpToDate. A second PubMed search was completed using the key terms musculoskeletal injections, hip injections, knee injections, ultrasound injections, and landmark guided injections. Search dates: November 22, 2022; January 20, 2023; May 1, 2023; and November 6, 2023.

CHARLES W. WEBB, DO, FAAFP, FAMSSM, is director of the Division of Sports Medicine, director of the Primary Care Sports Medicine Fellowship, and an associate professor in the Department of Family Medicine at Louisiana State University Health Shreveport School of Medicine.

GEOFF McLEOD, DO, FAAFP, CAQSM, is a surgeon and chief of medical operations at The Citadel, Charleston, S.C., and an assistant professor in the Department of Family Medicine at the Medical University of South Carolina, Charleston.

RATHNA NUTI, MD, FAAFP, CAQSM, is a family medicine-sports medicine physician at DFW Sports Medicine, McKinney, Tex.

Address correspondence to Charles W. Webb, DO, Louisiana State University Health Shreveport School of Medicine, 1501 Kings Hwy., P.O. Box 33932, Shreveport, LA 71130 (charles.webb@lsuhs.edu). Reprints are not available from the authors.

Author disclosure: No relevant financial relationships.

  1. 1.Hoeber S, Aly AR, Ashworth N, et al. Ultrasound-guided hip joint injections are more accurate than landmark-guided injections: a systematic review and meta-analysis. Br J Sports Med. 2016;50(7):392-396.
  2. 2.Rampal S, Jaiman A, Tokgöz MA, et al. A review of the efficacy of intraarticular hip injection for patients with hip osteoarthritis: to inject or not to inject in hip osteoarthritis?. Jt Dis Relat Surg. 2022;33(1):255-262.
  3. 3.Daniels EW, Cole D, Jacobs B, et al. Existing evidence on ultrasound-guided injections in sports medicine. Orthop J Sports Med. 2018;6(2) ): 2325967118756576.
  4. 4.Curtiss HM, Finnoff JT, Peck E, et al. Accuracy of ultrasound-guided and palpation-guided knee injections by an experienced and less-experienced injector using a superolateral approach: a cadaveric study. PM R. 2011;3(6):507-515.
  5. 5.Daley EL, Bajaj S, Bisson LJ, et al. Improving injection accuracy of the elbow, knee, and shoulder: does injection site and imaging make a difference? A systematic review. Am J Sports Med. 2011;39(3):656-662.
  6. 6.Diraçoğlu D, Alptekin K, Dikici F, et al. Evaluation of needle positioning during blind intra-articular hip injections for osteoarthritis: fluoroscopy versus arthrography. Arch Phys Med Rehabil. 2009;90(12):2112-2115.
  7. 7.Levi DS. Intra-articular hip injections using ultrasound guidance: accuracy using a linear array transducer. PM R. 2013;5(2):129-134.
  8. 8.Pourbagher MA, Ozalay M, Pourbagher A. Accuracy and outcome of sonographically guided intra-articular sodium hyaluronate injections in patients with osteoarthritis of the hip. J Ultrasound Med. 2005;24(10):1391-1395.
  9. 9.Smith J, Hurdle MFB, Weingarten TN. Accuracy of sonographically guided intra-articular injections in the native adult hip. J Ultrasound Med. 2009;28(3):329-335.
  10. 10.Ziv YB, Kardosh R, Debi R, et al. An inexpensive and accurate method for hip injections without the use of imaging. J Clin Rheumatol. 2009;15(3):103-105.
  11. 11.Cardone DA, Tallia AF. Diagnostic and therapeutic injection of the hip and knee. Am Fam Physician. 2003;67(10):2147-2152.
  12. 12.Stephens MB, Beutler AI, O’Connor FG. Musculoskeletal injections: a review of the evidence. Am Fam Physician. 2008;78(8):971-976.
  13. 13.Cato RK. Indications and usefulness of common injections for non-traumatic orthopedic complaints. Med Clin North Am. 2016;100(5):1077-1088.
  14. 14.Lynch TS, Oshlag BL, Bottiglieri TS, et al. Ultrasound-guided hip injections. J Am Acad Orthop Surg. 2019;27(10):e451-e461.
  15. 15.Bichsel D, Liechti FD, Schlapbach JM, et al. Cross-sectional analysis of recommendations for the treatment of hip and knee osteoarthritis in clinical guidelines. Arch Phys Med Rehabil. 2022;103(3):559-569.e5.
  16. 16.Blaichman JI, Chan BY, Michelin P, et al. US-guided musculoskeletal interventions in the hip with MRI and US correlation. Radiographics. 2020;40(1):181-199.
  17. 17.Chang KV, Wu WT, Lew HL, et al. Ultrasound imaging and guided injection for the lateral and posterior hip. Am J Phys Med Rehabil. 2018;97(4):285-291.
  18. 18.Jurgensmeier K, Jurgensmeier D, Kunz DE, et al. Intra-articular injections of the hip and knee with triamcinolone vs. ketorolac: a randomized controlled trial. J Arthroplasty. 2021;36(2):416-422.
  19. 19.Rowbotham EL, Grainger AJ. Ultrasound-guided intervention around the hip joint. AJR Am J Roentgenol. 2011;197(1):W122-W127.
  20. 20.Mulvaney SW. A review of viscosupplementation for osteoarthritis of the hip and a description of an ultrasound-guided hip injection technique. Curr Sports Med Rep. 2009;8(6):291-294.
  21. 21.Wernecke C, Braun HJ, Dragoo JL. The effect of intra-articular corticosteroids on articular cartilage: a systematic review. Orthop J Sports Med. 2015;3(5) ): 2325967115581163.
  22. 22.Kolasinski SL, Neogi T, Hochberg MC, et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the management of osteoarthritis of the hand, hip, and knee [published correction appears in Arthritis Care Res (Hoboken). 2021; 73(5): 764]. Arthritis Care Res (Hoboken). 2020;72(2):149-162.
  23. 23.Krishnamurthy A, Lang AE, Pangarkar S, et al. Synopsis of the 2020 US Department of Veterans Affairs/US Department of Defense Clinical Practice Guideline: the non-surgical management of hip and knee osteoarthritis. Mayo Clin Proc. 2021;96(9):2435-2447.
  24. 24.Hirsch G, Kitas G, Klocke R. Intra-articular corticosteroid injection in osteoarthritis of the knee and hip: factors predicting pain relief—a systematic review. Semin Arthritis Rheum. 2013;42(5):451-473.
  25. 25.Fusco G, Gambaro FM, Di Matteo B, et al. Injections in the osteoarthritic knee: a review of current treatment options. EFORT Open Rev. 2021;6(6):501-509.
  26. 26.Courtney P, Doherty M. Joint aspiration and injection and synovial fluid analysis. Best Pract Res Clin Rheumatol. 2013;27(2):137-169.
  27. 27.Maricar N, Parkes MJ, Callaghan MJ, et al. Where and how to inject the knee—a systematic review [published correction appears in Semin Arthritis Rheum. 2015; 44(5): e18]. Semin Arthritis Rheum. 2013;43(2):195-203.
  28. 28.Pavone V, Vescio A, Turchetta M, et al. Injection-based management of osteoarthritis of the knee: a systematic review of guidelines. Front Pharmacol. 20, 2021;12:661805.
  29. 29.Billesberger LM, Fisher KM, Qadri YJ, et al. Procedural treatments for knee osteoarthritis: a review of current injectable therapies. Pain Res Manag. 2020;2020:3873098.
  30. 30.Yavuz U, Sökücü S, Albayrak A, et al. Efficacy comparisons of the intraarticular steroidal agents in patients with knee osteoarthritis. Rheumatol Int. 2012;32(11):3391-3396.
  31. 31.McAlindon TE, LaValley MP, Harvey WF, et al. Effect of intra-articular triamcinolone vs. saline on knee cartilage volume and pain in patients with knee osteoarthritis: a randomized clinical trial. JAMA. 2017;317(19):1967-1975.
  32. 32.Berkoff DJ, Miller LE, Block JE. Clinical utility of ultrasound guidance for intra-articular knee injections: a review. Clin Interv Aging. 2012;7:89-95.
  33. 33.Dixit S, DiFiori JP, Burton M, et al. Management of patellofemoral pain syndrome. Am Fam Physician. 2007;75(2):194-202.
  34. 34.Bunt CW, Jonas CE, Chang JG. Knee pain in adults and adolescents: the initial evaluation. Am Fam Physician. 2018;98(9):576-585.
  35. 35.Tandeter HB, Shvartzman P, Stevens MA. Acute knee injuries: use of decision rules for selective radiograph ordering. Am Fam Physician. 1999;60(9):2600.
  36. 36.Tognolo L, Maccarone MC, De Trane S, et al. Therapeutic exercise and conservative injection treatment for early knee osteoarthritis in athletes: a scoping review. Medicina (Kaunas). 2022;58(1):69.
  37. 37.Lundstrom ZT, Sytsma TT, Greenlund LS. Rethinking viscosupplementation: ultrasound-versus landmark-guided injection for knee osteoarthritis. J Ultrasound Med. 2020;39(1):113-117.
  38. 38.Khaund R, Flynn SH. Iliotibial band syndrome: a common source of knee pain. Am Fam Physician. 2005;71(8):1545-1550.

Copyright © 2026 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.